RISEDRONATE

risedronate sodium 35 mg enteric tablet, 4

RISEDRONATE (2191H)

risedronate sodium 35 mg enteric tablet, 4
2191H
Body System:
Manner of administration:Oral
Repatriation Pharmaceutical Benefits
Authority Required

Restriction

Indication: Preservation of bone mineral density
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 4 # of repeats: 5 DPMQ: - Max safety net: - General Patient Charge: -
Available brands
Actonel EC DPMQ: $34.21 Max safety net: $7.70 General Patient Charge: $7.70